• 8 May 2018

    Barriers impede biosimilar market entry into the US

    Back in 2010, the FDA implemented the Biologics Price Competition and Innovation Act (BPCIA) as part of the Affordable Care Act (ACA), which created an abbreviated pathway for biosimilar drug...

Close
Close
Close

Go Top